Long-Term Safety of Tirzepatide for Type 2 Diabetes Patients Confirmed
A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
Abstract
A Phase 3, Long-Term Safety Study of Tirzepatide in Combination With Monotherapy of Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus (SURPASS J-combo)
NCT ID: NCT03861039
Status: COMPLETED
Sponsor: Eli Lilly and…